• Home
  • Search Results
  • Photophysical properties of Atto655 dye in the presence of guanosine and tryptophan in aqueous solution.

Photophysical properties of Atto655 dye in the presence of guanosine and tryptophan in aqueous solution.

The journal of physical chemistry. B (2011-04-12)
Ruixue Zhu, Xun Li, Xin Sheng Zhao, Anchi Yu
ABSTRACT

Atto655 has been widely used as an excellent probing dye through photoinduced electron transfer (PET) for biochemical processes in oligonucleotides or polypeptides. However, its photophysical properties in the presence of the quenchers guanosine and tryptophan have not been carefully studied. In this work, we investigated the dynamics of PET between Atto655 and the two quenchers in aqueous solution with femtosecond transient absorption experiments. We derived that the charge separation rate is 8.1 × 10(9) s(-1) and the charge recombination rate is 7.7 × 10(10) s(-1) for the collision complex between Atto655 and guanosine and that the corresponding values for the collision complex between Atto655 and tryptophan are 4.0 × 10(11) and 5.0 × 10(12) s(-1), respectively. These experimental results are quite consistent with the prediction of Marcus-type theory for electron transfer. The implications of this work for the data analysis of PET-based fluorescence correlation spectroscopy are discussed.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Atto 655, BioReagent, suitable for fluorescence, ≥85% (HPLC)
Sigma-Aldrich
Atto 655 NHS ester, BioReagent, suitable for fluorescence
Sigma-Aldrich
Atto 655-Biotin, BioReagent, suitable for fluorescence, ≥95.0% (HPCE)
Sigma-Aldrich
Atto 655 amine, suitable for fluorescence
Sigma-Aldrich
Atto 655-maleimide, BioReagent, suitable for fluorescence, ≥90% (coupling rate)

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.